Chargement en cours...
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
OBJECTIVE: To compare the efficacy and safety of treatment with infliximab plus methotrexate with methotrexate alone in methotrexate-naive patients with active psoriatic arthritis (PsA). METHODS: In this open-label study, patients 18 years and older with active PsA who were naive to methotrexate and...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Group
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3298666/ https://ncbi.nlm.nih.gov/pubmed/21994233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.152223 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|